Child Psychiatry
Child Psychiatry RSS Feed RSS

The Politics of Medicating Children: Problems and Solutions

September 1, 2015
Investigative journalist Karen de Sá wrote a series for the San Jose Mercury News called “Drugging Our Kids” about medication treatment of foster children. She found that almost one in four foster children between 12 and 17 were receiving a psychotropic of some kind, and 62% were receiving an antipsychotic. Her reporting spurred the California legislature to pass several laws designed to discourage the excessive use of psychotropics in foster children.
Read More

Medication Strategies for Helping People with Autism Spectrum Disorders

July 1, 2015
Joshua Feder, MD
Getting meds just right is challenging in autism. Sometimes we succeed, sometimes it doesn't work out so well. No two people with Autism Spectrum Disorder are alike, meaning that our medication choices have to be individualized even more so than in most other psychiatric syndromes.
Read More

Evaluating and Treating Autism: Practical Issues

July 1, 2015

Alex Kolevzon, MD

Associate Professor of Psychiatry and Pediatrics at Mount Sinai Hospital, New York, NY Dr. Kolevzon has disclosed payments for research support from Neuren Pharmaceuticals for NNZ-2566 (an investigational drug for Rett Syndrome) and Hoffman-La Roche for RO5285119 (an investigational drug for autism). Dr. Carlat has reviewed this interview and found no evidence of bias in this educational activity.

Dr. Kolevzon shares his clinical strategies for treating autism spectrum disorder in child patients, including diagnostic behaviors and communicating with parents.
Read More

Medications for Childhood PTSD: It’s All Off-Label

May 1, 2015
Elizabeth Tien, MD

Elizabeth Tien, MD. Child, Adolescent and Adult Psychiatrist with Maimonides Medical Center in Brooklyn, NY.                                      

Dr. Tien has declared that she has no relevant financial or other interest in any commercial companies pertaining to this activity.

In 2011, we wrote a review of medications for PTSD in children and found, unfortunately, that data to inform true evidence-based practice was scant. There are still no psychotropic medications that have been proven effective in randomized controlled trials for children with PTSD and there are no FDA approved medications for this population.
Read More

An Intensive Autism Treatment Program Looks Promising

May 1, 2015
Autism is fairly common and is extremely hard to treat. A couple of antipsychotics (Risperdal, Abilify) can help decrease the agitation common in autism, and some behavior therapies can improve the ability to interact with others. But these behavioral techniques have only been studied in the short term—which is not very helpful, because autism is a long term problem.
Read More

Should You Be Monitoring Serum Levels of Atypical Antipsychotics in Kids?

May 1, 2015
For better or worse, we are prescribing atypical antipsychotics more frequently in children. Some of this is due to new FDA indications for kids (autism, psychotic disorders, and bipolar disorder), but much of the increase is driven by off-label use (Tourette’s, ADHD, OCD, depression, conduct disorder and impulse control disorders).
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.